|
1
|
Sherman DS, Fish DN and Teitelbaum I:
Assessing renal function in cirrhotic patients: Problems and
pitfalls. Am J Kidney Dis. 41:269–278. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shlipak MG, Mattes MD and Peralta CA:
Update on cystatin C: Incorporation into clinical practice. Am J
Kidney Dis. 62:595–603. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang D, Feng JF, Wang AQ, Yang YW and Liu
YS: Role of cystatin C and glomerular filtration rate in diagnosis
of kidney impairment in hepatic cirrhosis patients. Medicine
(Baltimore). 96(e6949)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yoo JJ, Kim SG, Kim YS, Lee B, Lee MH,
Jeong SW, Jang JY, Lee SH, Kim HS, Kim YD and Cheon GJ: Estimation
of renal function in patients with liver cirrhosis: Impact of
muscle mass and sex. J Hepatol. 70:847–854. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mindikoglu AL, Opekun AR, Mitch WE, Magder
LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD,
Raufman JP, et al: Cystatin C is a gender-neutral glomerular
filtration rate biomarker in patients with cirrhosis. Dig Dis Sci.
63:665–675. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ying X, Jiang Y, Qin G, Qian Y, Shen X,
Jiang Z, Zheng S and Song Z: Association of body mass index, waist
circumference, and metabolic syndrome with serum cystatin C in a
Chinese population. Medicine (Baltimore). 96(e6289)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
DSa J, Shetty S, Bhandary RR and Rao AV:
Association between serum cystatin C and creatinine in chronic
kidney disease subjects attending a tertiary health care centre. J
Clin Diagn Res. 11:BC09–BC12. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Miliku K, Bakker H, Dorresteijn EM,
Cransberg K, Franco OH, Felix JF and Jaddoe VW: Childhood estimates
of glomerular filtration rate based on creatinine and cystatin C:
Importance of body composition. Am J Nephrol. 45:320–326.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Takeuchi M, Fukuda Y, Nakano I, Katano Y
and Hayakawa T: Elevation of serum cystatin C concentrations in
patients with chronic liver disease. Eur J Gastroenterol Hepatol.
13:951–955. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Francoz C, Nadim MK and Durand F: Kidney
biomarkers in cirrhosis. J Hepatol. 65:809–824. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kashani KB, Frazee EN, Kukrálová L,
Sarvottam K, Herasevich V, Young PM, Kashyap R and Lieske JC:
Evaluating muscle mass by using markers of kidney function:
Development of the sarcopenia index. Crit Care Med. 45:e23–e29.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Barreto EF, Poyant JO, Coville HH,
Dierkhising RA, Kennedy CC, Gajic O, Nystrom EM, Takahashi N,
Moynagh MR and Kashani KB: Validation of the sarcopenia index to
assess muscle mass in the critically ill: A novel application of
kidney function markers. Clin Nutr. 38:1362–1367. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kashani K, Sarvottam K, Pereira NL,
Barreto EF and Kennedy CC: The sarcopenia index: A novel measure of
muscle mass in lung transplant candidates. Clin Transplant.
32(e13182)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Osaka T, Hamaguchi M, Hashimoto Y,
Ushigome E, Tanaka M, Yamazaki M and Fukui M: Decreased the
creatinine to cystatin C ratio is a surrogate marker of sarcopenia
in patients with type 2 diabetes. Diabetes Res Clin Pract.
139:52–58. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tamai Y, Iwasa M, Kawasaki Y, Yoshizawa N,
Ogura S, Sugimoto R, Eguchi A, Yamamoto N, Sugimoto K, Hasegawa H
and Takei Y: Ratio between estimated glomerular filtration rates of
creatinine and cystatin C predicts overall survival in patients
with hepatocellular carcinoma. Hepatol Res. 49:153–163.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
van Vugt JLA, Alferink LJM, Buettner S,
Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA,
Polak WG, Porte RJ, et al: A model including sarcopenia surpasses
the MELD score in predicting waiting list mortality in cirrhotic
liver transplant candidates: A competing risk analysis in a
national cohort. J Hepatol. 68:707–714. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Golse N, Bucur PO, Ciacio O, Pittau G, Sa
Cunha A, Adam R, Castaing D, Antonini T, Coilly A, Samuel D, et al:
A new definition of sarcopenia in patients with cirrhosis
undergoing liver transplantation. Liver Transplant. 23:143–154.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Yamashima M, Miyaaki H, Honda T, Shibata
H, Miuma S, Taura N and Nakao K: Significance of psoas muscle
thickness as an indicator of muscle atrophy in patients with
hepatocellular carcinoma treated with sorafenib. Mol Clin Oncol.
7:449–453. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fujiwara N, Nakagawa H, Kudo Y, Tateishi
R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami
T, et al: Sarcopenia, intramuscular fat deposition, and visceral
adiposity independently predict the outcomes of hepatocellular
carcinoma. J Hepatol. 63:131–140. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nishikawa H, Shiraki M, Hiramatsu A,
Moriya K, Hino K and Nishiguchi S: Japan society of hepatology
guidelines for sarcopenia in liver disease (1st edition):
Recommendation from the working group for creation of sarcopenia
assessment criteria. Hepatol Res. 46:951–963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kim SW, Jung HW, Kim CH, Kim KI, Chin HJ
and Lee H: A new equation to estimate muscle mass from creatinine
and cystatin C. PLoS One. 11(e0148495)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hiraoka A, Aibiki T, Okudaira T, Toshimori
A, Kawamura T, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y,
et al: Muscle atrophy as pre-sarcopenia in Japanese patients with
chronic liver disease: Computed tomography is useful for
evaluation. J Gastroenterol. 50:1206–1213. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Child CG and Turcotte JG: Surgery and
portal hypertension. Major Probl Clin Surg. 1:1–85. 1964.PubMed/NCBI
|
|
24
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649.
1973.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Johnson PJ, Berhane S, Kagebayashi C,
Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A,
Palmer D, et al: Assessment of liver function in patients with
hepatocellular carcinoma: A new evidence-based approach-the ALBI
grade. J Clin Oncol. 33:550–558. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kamath P, Wiesner RH, Malinchoc M, Kremers
W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER and Kim WR: A
model to predict survival in patients with end-stage liver disease.
Hepatology. 33:464–470. 2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vallet-Pichard A, Mallet V, Nalpas B,
Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H and Pol S:
FIB-4: an inexpensive and accurate marker of fibrosis in HCV
infection. Comparison with liver biopsy and fibrotest. Hepatology.
46:32–36. 2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Levey AS, de Jong PE, Coresh J, El Nahas
M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL and Eckardt
KU: The definition, classification, and prognosis of chronic kidney
disease: A KDIGO controversies conference report. Kidney Int.
80:17–28. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Patel SS, Molnar MZ, Tayek JA, Ix JH,
Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP and
Kalantar-Zadeh K: Serum creatinine as a marker of muscle mass in
chronic kidney disease: Results of a cross-sectional study and
review of literature. J Cachexia Sarcopenia Muscle. 4:19–29.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hsieh YC, Lee KC, Wang YW, Yang YY, Hou
MC, Huo TI and Lin HC: Correlation and prognostic accuracy between
noninvasive liver fibrosismarkers and portal pressure in cirrhosis:
Role of ALBI score. PLoS One. 13(e0208903)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Baxmann AC, Ahmed MS, Marques NC, Menon
VB, Pereira AB, Kirsztajn GM and Heilberg IP: Influence of muscle
mass and physical activity on serum and urinary creatinine and
serum cystatin C. Clin J Am Soc Nephrol. 3:348–354. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tufan A, Tufan F, Akpinar TS, Ilhan B,
Bahat G and Karan MA: Low glomerular filtration rate as an
associated risk factor for sarcopenic muscle strength: Is
creatinine or cystatin C-based estimation more relevant? Aging
Male. 20:110–114. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lino VT, Rodrigues NC, O'Dwyer G, Andrade
MK, Mattos IE and Portela MC: Handgrip strength and factors
associated in poor elderly assisted at a primary care unit in Rio
de Janeiro, Brazil. PLoS One. 11(e0166373)2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Souweine JS, Kuster N, Chenine L,
Rodriguez A, Patrier L, Morena M, Badia E, Chalabi L, Raynal N,
Ohresser I, et al: Physical inactivity and protein energy wasting
play independent roles in muscle weakness in maintenance
haemodialysis patients. PLoS One. 13(e0200061)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Isoyama N, Qureshi AR, Avesani CM,
Lindholm B, Bárány P, Heimbürger O, Cederholm T, Stenvinkel P and
Carrero JJ: Comparative associations of muscle mass and muscle
strength with mortality in dialysis patients. Clin J Am Soc
Nephrol. 9:1720–1728. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mazurak VC, Tandon P and Montano-Loza AJ:
Nutrition and the transplant candidate. Liver Transplant.
23:1451–1464. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Clark BC and Manini TM: Functional
consequences of sarcopenia and dynapenia in the elderly. Curr Opin
Clin Nutr Metab Care. 13:271–276. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Han E, Lee YH, Kim BK, Park JY, Kim DY,
Ahn SH, Lee BW, Kang ES, Cha BS, Han KH and Kim SU: Sarcopenia is
associated with the risk of significant liver fibrosis in
metabolically unhealthy subjects with chronic hepatitis B. Aliment
Pharmacol Ther. 48:300–312. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
He Q, Jiang J, Xie L, Zhang L and Yang M:
A sarcopenia index based on serum creatinine and cystatin C cannot
accurately detect either low muscle mass or sarcopenia in urban
community-dwelling older people. Sci Rep. 8(11534)2018.PubMed/NCBI View Article : Google Scholar
|
